SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Gland Pharma

BSE: 543245 22 Aug 2025
Healthcare
₹ 1950.7
Gland Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

Gland Pharma - Share Price & Details

Market Cap
₹32,042
High /Low
2,131 / 1,200
Stock P/E
41.6
Book Value
₹555.0
Dividend Yield
0.93
ROCE
11.9
ROE
₹7.81
Face Value
1.0
PEG Ratio
-2.49
EVEBITDA
₹18.7
Debt
314
CMP / FCF
76.2
Debt to equity
₹0.03
NP Ann
699
High price all time
4,350
Piotroski score
₹5.0
Graham Number
764.0
No. Eq. Shares
16.5
Net CF
₹2,199
Net profit
770
Price to book value
3.5
Interest Coverage
₹25.2
Low price all time
861.0
Industry PE
32.8
Reserves
₹9,134
Free Cash Flow
₹521

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
Gland Pharma Limited10935.762692.5810388.3516.3432,04241.6
Aster DM Healthcare Limited6514.7805.96130.41.573146389.0
Krishna Institute of Medical S3856.0588.03734.01.472985680.9

Peer Comparison Chart


About Gland Pharma

Gland Pharma Limited, with Security Code 543245, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

HUL, Thermax, Gland Pharma, Capital India Home, Vodafone, CG Power among others will remain in focus on Wednesday (August 13, 2025)

(13 Aug 2025)
Hindustan Unilever Ltd (HUL) shareholders have approved the demerger of the ice-cream business into an independent listed entity.
Read more →

Gland Pharma receives FDA approval for Cangrelor for Injection 50 mg/vial

(12 Aug 2025)
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA.
Read more →

Gland Pharma bags USFDA nod for Cangrelor for Injection

(12 Aug 2025)
Hyderabad: Gland Pharma Limited, a generic injectable & ophthalmic focused pharmaceutical company, has announced that the company has...
Read more →

Gland Pharma gets approval for Norepinephrine Bitartrate in 5% Dextrose injection bags

(12 Aug 2025)
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of...
Read more →

Gland Pharma share price target at Rs 2,340: MOFSL sees 19% upside, retains Buy

(12 Aug 2025)
Motilal Oswal Financial Services Limited (MOFSL) has adjusted its target price for Gland Pharma to Rs 2,340, valuing the company at 33 times 12-month...
Read more →

Gland Pharma Limited (NSE:GLAND) Is About To Go Ex-Dividend, And It Pays A 0.9% Yield

(10 Aug 2025)
NSEI:GLAND 1 Year Share Price vs Fair Value Explore Gland Pharma's Fair Values from the Community and select yours...
Read more →

Company Updates